A few hundred years ago my Cowan ancestor got on a boat in Scotland and headed west. I have been to Edinburgh in the winter, so I am grateful to him for many reasons.
A report from the BBC reminded me of another reason:
“Scotland’s first medical cannabis clinic has begun prescribing to patients suffering from chronic pain conditions… The Sapphire Medical Clinic in Stirling was approved by regulators in March and… provides unlicensed cannabis-based medicines for people with conditions that do not meet the criteria for NHS-prescribed cannabis products… Medical cannabis was legalised in the UK in November 2018 and doctors are allowed to prescribe it in certain situations.”
“The 2018 law change moved cannabis from schedule 1 under the Misuse of Drugs Regulations 2001 – meaning it had no therapeutic value – to schedule 2. It now means doctors can prescribe the drug in certain situations… Many other cannabis products are unlicensed but can still be prescribed privately.”
See: “UK Data Show Marijuana Prohibition Is A Racist Counterproductive Fraud”
A Healthcare Improvement Scotland spokesperson said unlicensed cannabis-based medical products should be prescribed by specialist clinicians “where there is clear published evidence of benefit” and where there is a “clinical need which cannot be met by licensed medicines and where established medicines have been exhausted.”
In other words, when the patients have suffered enough, they may be allowed to try cannabinoids.
I would cheer, “Scotland Forever!”… if this had not taken forever.
There are millions of Americans like me whose ancestors came from that island and are essentially “bio-identical” to the otherwise free Scottish people who have had to suffer for years before the politicians and bureaucrats decided that they are worthy of a loophole.
The statement added: “Independent clinics must ensure that appropriate consultations take place, that clinicians make informed assessments, that informed patient consent is obtained in accordance with the law and professional guidelines, and that patients understand the risk and benefits of a treatment or medication. Moreover, clinicians should make it clear to patients if there is only limited evidence of the effectiveness of the chosen treatment.”
See full here: